SpringWorks Therapeutics Updates Filing for $143+ Million IPO

Pfizer biotech spinout, Springworks Therapeutics, updated it IPO filing on 9/3/19. The company will raise up to $143 million and offer 7,352,941 shares. Springworks is a clinical-stage biopharmaceutical company launched in 2017 with several Pfizer assets and a $103 million Series A round. The company will trade on NASDAQ under the symbol “SWTX.”